Efficacy of anti-PD(L)1 treatment in patients with metastatic urothelial cancer based on mRNA- and protein- based PD-L1 determination: Results from the multicentric, retrospective FOsMIC trial

Jarczyk, J. and Wirtz, R. and Roghmann, F. and Juette, H. and Kriegmair, M. C. and Worst, T. S. and Sikic, D. and Wach, S. and Taubert, H. and Wullich, B. and Weyerer, V. and Stoehr, R. and Zengerling, F. and Bolenz, C. and Breyer, J. and Burger, M. and Porubsky, S. and Hartmann, A. and Erben, P. and Eckstein, M. (2019) Efficacy of anti-PD(L)1 treatment in patients with metastatic urothelial cancer based on mRNA- and protein- based PD-L1 determination: Results from the multicentric, retrospective FOsMIC trial. ANNALS OF ONCOLOGY, 30 (Suppl5). pp. 378-379. ISSN 0923-7534, 1569-8041

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Urologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 24 Mar 2020 11:53
Last Modified: 24 Mar 2020 11:53
URI: https://pred.uni-regensburg.de/id/eprint/26083

Actions (login required)

View Item View Item